1. Synergistic action of first-in-class anti-tropomyosin compound, ATM-3507 (Anisina) and microtubule targeting inhibitors in pre-clinical models of non-small cell lung cancer (NSCLC). (December 2016) Authors: Stehn, J.; Mariana, A.; Failes, T.; Ashokakumar, V.; Eiffe, E.; Heaton, A.; Hook, J.; Sivanandhan, D.; Arndt, G.; Gunning, P.; Brown, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗